Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the tolerability and efficacy of a combination of
weekly docetaxel, cisplatin, and S-1 (weekly TPS) as induction chemotherapy in patients with
locally advanced head and neck squamous cell carcinoma (HNSCC).
Phase:
Phase 2
Details
Lead Sponsor:
Chonnam National University Hospital
Collaborators:
Chonbuk National University Chungbuk National University Chungnam National University